4th Annual Genome Editing USA Congress

Hits:1060   Date: 12/16/2019

07 - 08 April 2020, Boston, USA

Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

 

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

 

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

 

07 April 2019 – Day One

Genome Editing Technologies & Techniques

Drug Discovery & Development Applications in In Vivo Therapeutics

08 April 2019 – Day Two

Drug Discovery & Development – Target Identification and Validation

Non-Human Models in Diagnostics & Therapeutics

 

View Agenda: http://bit.ly/2PlzXTQ

 

2020 Live Webinar

Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now

Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.

Tuesday, 10 March 2020 | 03:30 PM GMT

Register: https://bit.ly/2QvO7Us 

 

Contact us

Bradley Copeman
Tel: +441865248455
Email: b.copeman@oxfordglobal.co.uk